cortexin

01/01/2020 - "[Comparison of the efficacy of Cellex and Cortexin in patients in the early recovery period of ischemic stroke]."
01/01/2016 - "[Efficacy of cortexin in acute and recovery periodes of hemispheric ischemic stroke]."
01/01/2008 - "The data obtained suggest an efficacy of cortexin in the treatment of patients with acute ischemic stroke as compared to placebo. "
01/01/2018 - "To study the efficacy and prolonged effect of repeated treatment with low-doses of the neuroprotection drug cortexin (30 mg, (10+10+10, morning, noon, day), daily) in patients in the acute period of hemispheric ischemic stroke. "
01/01/2016 - "To study the effectiveness and sustained effects of early appointment of a repeated course of low-dose drug cortexin neuroprotection in patients in acute and recovery period of hemispheric ischemic stroke. "

01/01/2021 - "Thus, Cortexin, 1 or 3 mg/kg, or Cerebrolysin®, 538 or 1614 mg/kg, were effective in models acute and chronic brain ischemia in rats. "
01/01/2018 - "To study an effect of cortexin on neurological symptoms and oxidative stress as part of the ischemic cascade in chronic cerebral ischemia (CCI), I-II stages. "
01/01/2018 - "[Dose-dependent effects of cortexin in chronic cerebral ischemia (results of a multicenter randomized controlled study)]."
01/01/2014 - "[An open clinical trial of cortexin in treatment of brain ischemia]."
01/01/2014 - "The results of the all-Russian screening of cortexin efficacy "Cognitive and affective disorders during treatment brain ischemia with cortexin" conducted in 50 000 patients with BI in 70 Russian cities in 2013 were used for an analysis. "

01/01/2018 - "[Results of a multicenter study on the efficacy of cortexin in treatment of cognitive dysfunction in children]."
01/01/2018 - "The authors present the results of the multicenter observational program 'KORMEN' that studied the efficacy of cortexin and memantinol in the treatment of cognitive impairment in patients with CCI. "
01/01/2018 - "To study the efficacy and tolerability of cortexin in the treatment of cognitive dysfunction in children. "
01/01/2018 - "Experience of using cortexin, which compensates for cognitive impairment and improves social adaptation, is discussed. "
01/01/2018 - "The reliable effect of cortexin on cognitive impairment was shown. "

01/01/2020 - "To study the therapeutic efficacy of two treatment modes of peptidergic nootropic medication cortexin in children with developmental dysphasia aged 3-4 years. "
01/01/2019 - "To study the therapeutic efficacy of peptidergic nootropic medication Cortexin during two-month follow-up in children with developmental dysphasia aged 3-4 years. "
01/01/2020 - "The results of the study confirm the higher effectiveness of two courses of the peptidergic nootropic medication cortexin in the pharmacotherapy of developmental dysphasia in children, aged 3-4 years, conducted over two months, compared with the indication of one treatment course. "
01/01/2019 - "Combined neuroprotective therapy using drugs with neuromodulatory and antioxidant effects (cortexin and mexidol) in the acute period of ischemic stroke is effective in the treatment of post-stroke aphasia. "

01/01/2009 - "The significantly better rehabilitation (p<0,05) of motor and cognitive functions after stroke damage, improvement in the brain bioelectric activity (the increase of alpha-activity and the decrease of slow-wave activity and sharp waves in the projection of ischemic zone) were found in patients treated with cortexin. "
01/01/2019 - "Use of cortexin during rehabilitation in stroke patients with a neglect syndrome is justified and expedient for the increase of its efficiency that permits to recommend this drug for wide use in clinical practice. "
01/01/2019 - "The combined rehabilitation with the use of cortexin helps to remove the neglect syndrome and improve the functional rehabilitation of stroke patients. "
01/01/2016 - "It is shown that the optimal scheme for the purpose of Cortexin includes: intramuscular administration of Cortexin in the dose of 20 mg (10 mg morning + 10 mg evening) for 10 days, with a repeat the same course within 10 days after the first, since the first 6 h after the onset of stroke symptoms. "
03/01/2004 - "[Use of cortexin electrophoresis in the prophylaxis of cerebral strokes]."